SCGC-Backed Innovative Antibody Drug Firm Gets $150M Funding From Sino Biopharm
November 5, 2019 — 10:54 CST
This Data Is Locked!
This area is available only to Subscribers.
Akeso Biopharma, an innovative biotechnology company, announced that it has raised nearly US$150 million in a series D funding round led by private equity firm... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals